Michael Bova, MD
Pain Medicine · Lebanon, NHNPI 1720548159
Payments from drug & device makers
What this record shows
This record is dominated by grants: $10,000 of the $11,801 with a category attached, or 84.7%. Abbott accounts for 84.7% of it on its own, with 6 other manufacturers making up the rest. Reporting peaked in 2023 at $11,607 and has fallen 99.0% since, to $112 in 2025.
Across 17 payments — averaging $694.16 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Abbott$10K
- Medtronic$1K
- SPR Therapeutics, Inc$241
- Vertex$53
- Boston Scientific$23
- Averitas Pharma Inc.$13
- plus $7 from 1 others
What the payments were for
- Grants$10,00085%
- Travel & lodging$1,25811%
- Food & beverage$5435%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Abbott | 1 | $10,000 |
| Medtronic | 9 | $1,465 |
| SPR Therapeutics, Inc | 3 | $241 |
| Vertex | 1 | $53 |
| Boston Scientific | 1 | $23 |
| Averitas Pharma Inc. | 1 | $13 |
| Saluda Medical Americas, Inc. | 1 | $7 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- VANTA ADAPTIVESTIM$1,078
- SPRINT PNS System$112
How this compares
$11,801 in reported general payments places this provider in the 85th percentile of 38 pain medicine providers in New Hampshire.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Celecoxib | 39 | $1,796 |
| Pregabalin | 23 | $468 |
| Gabapentin | 16 | $207 |
| Meloxicam | 11 | $60 |
| Naproxen | 11 | $42 |
Paid to pharmacies, not to this prescriber.
Other pain medicine in Lebanon
- Bert FichmanLebanon$15K
- George LantzLebanon$5K
- Jason DonnellyLebanon$2K
- Abdullah KandilLebanon$1K
- Stephen LordonLebanon$322
- Mary Ann SurielLebanon$278
- Jeffrey BradyLebanon$277
- Kimberly YoungrenLebanon$223
- Bruce VroomanLebanon$182
- David DentLebanon$52
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.